Tumor vasculature : a target for anticancer therapies / Dietmar W. Siemann -- Abnormal microvasculature and defective microcirculatory function in solid tumors / Peter Vaupel -- The role of microvasculature in metastasis formation / Oliver Stöltzing, Lee M. Ellis -- Development of agents that selectively disrupt tumor vasculature : a historical perspective / David J. Chaplin, Sally A. Hill -- Morphologic manifestations of vascular-disrupting agents in preclinical models / Mumtaz V. Rojiani, Amyn Rojiani -- Molecular recognition of the colchicine binding site as a design paradigm for the discovery and development of vascular disrupting agents / Kevin G. Pinney -- Combined modality approaches using vascular-disrupting agents / Wenyin Shi, Michael R. Horsman, Dietmar W. Siemann -- Vascular-targeting therapies and hyperthermia / Michael R. Horsman, Rumi Murata -- Flavones and xanthenones as vascular-disrupting agents / Bronwyn G. Siim, Bruce C. Baguley -- Targeting inside-out phospholipids on tumor blood vessels in pancreatic cancer / Adam W. Beck, Rolf Brekken, Philip E. Thorpe -- Cadherin antagonists as vascular-targeting agents / Orest Blaschuk, Tracey M. Rowlands -- Alphastatin : a pluripotent inhibitor of activated endothelial cells / Carolyn A. Staton, Claire Lewis -- Cationic lipid complexes to target tumor endothelium / Uwe Michaelis, Michael Teifel -- Development of vascular-targeting cancer gene therapy / Graeme J. Dougherty, Peter D. Davis, Shona T. Dougherty -- Vascular-disrupting strategies combined with bacterial spores targeting hypoxic regions of solid tumors / G-One Ahn, J. Martin Brown -- Imaging the effects of vascular-targeting agents / Susan M. Galbraith -- Clinical progress in tumor vasculature-disrupting therapies / Andrew M. Gaya, Gordon J. S. Rustin -- Use of vascular-disrupting agents in non-oncology indications / Joseph C. Randall, Scott Young